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Abstract Viral vectors are valuable tools to deliver
genetic materials into cells. Vectors derived from
human immunodeficiency virus type 1 are being widely
used for gene delivery, mainly because they are able to
transduce both dividing and non-dividing cells which
leads to stable and long term gene expression. In
addition, these types of vectors are safe, with low
toxicity, high stability and cell type specificity. There-
fore, this work was aimed to produce lentivirus-based
vector using a three-plasmid system. To produce this
system, the eGFP marker gene was cloned into the
plasmid pWPXLd. Subsequently, this vector plasmid,
along with packaging plasmids, psPAX2 and envelope
plasmid, pMD2.G, was co-transfected into packaging
cell line (293T) using calcium phosphate method. 48 h
post transfection, the constructed viral vector was
harvested, purified and concentrated and stored at
-80 C for next experiments. The titration of the vector
was carried out, using ELISA, flowcytometry, and
fluorescent microscopy. Finally, transduction of HEK-
293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell
lines was carried out with indicated cell numbers and
multiplicities of infections of the vector in the presence
of polybrene. Using this system, high titer lentivirus at
titers of up to 2 9 108 transducing units/ml (TU/ml)
was successfully generated and its transduction efficacy
was improved by seven to over 20-fold in various cell
types. We demonstrate the applicability of this vector
for the efficient transduction of dividing and non-
dividing cells, including HEK-293T, CHO, HepG2,
MCF-7, MEFs and Jurkat cell line. Transduction
efficiency yielded titers of (6.3 ± 1.2) 105 TU/ml.
Furthermore, lentivirus transferred transgene was
expressed at high level in the target cells and expression
was followed until 90 days after transduction. Thus, the
vector generated in this work, might be able to deliver
the transgene into a wide range of mammalian cells.
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Introduction
Numerous researches have been carried out to estab-
lish the genes delivery methods to introduce genes of
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interest (GOI) into the mammalian cells for stable and
efficient expression of the GOI. These valuable
researches, result in the expression of a wide range
of methods such as Ca-phosphate precipitation,
DEAE-dextran transfection, electroporation, and lipo-
some for delivery of DNA into mammalian cells. None
of these transfection methods are comparable with
viral methods with respect to simplicity, efficiency,
and straightforwardness.
Among the virus based methods, the lentivirus
based vectors are very efficient gene delivery vehicles
and are able to provide long-term gene expression.
Along with the increasing use of lentiviral vectors, the
production and purification procedures for the gener-
ation of these highly efficient vectors need to be
developed (Segura et al. 2010). It has been shown that
a variety of production systems efficiently generate
transduction competent lentiviral particles, including
transient transfection of mammalian cells (Naldini
et al. 1996) and use of stable packaging cell lines
(Kafri et al. 1999). Transient transfection approach
that uses multiplasmids continues to be the most
common techniques for lentiviral production because
it is faster, simpler and more versatile than the other
methods. Developing of stable packaging cell line for
lentiviral production is a tedious and time consuming
process and also, cytotoxicity of viral components or
transgenes can be a serious barrier (Bartz et al. 1996;
Konvalinka et al. 1995; Li et al. 1995; Miyazaki et al.
1995). Furthermore, transient-transfection systems
permit testing various transgene of interest and
envelope proteins with alternative cell tropism in a
relatively short time (Sena-Esteves et al. 2004). Many
detailed protocols are available describing production
of lentiviral vectors by multiplasmids transient trans-
fection of human embryonic kidney (HEK) 293 T cells
using different transfection reagents such as calcium
phosphate or lipofectamine (Follenzi and Naldini
2002; Tiscornia et al. 2006; Salmon and Trono
2001). In these protocols producer cells are grown as
monolayer in 10 or 15 cm culture dishes in the
presence of 10 % fetal bovine serum (FBS). Following
the successful transfection, 10–15 ml of supernatant
containing 105–107 infective lentiviral particles per ml
(IVP/ml) can be harvested at day 2 and 3 post
transfection. Subsequently, the harvested supernatants
are pooled, filtered through 0.45 nm filter to remove
cell debris. Increased titers can be achieved by
ultracentrifugation or ultrafiltration of virus-
containing cell culture supernatant, using a protocol
initially developed for concentration of MoMLV
vectors (Burns et al. 1993). Pseudotype lentiviral
particles containing the Vesicular Stomatitis Virus
glycoprotein (VSV-G) has shown to be stable and to
withstand concentration by ultracentrifugation with-
out significant loss in titer (Naldini et al. 1996; Bartz
and Vodicka 1997). This facilitates the generation of
highly concentrated vector stocks for applications that
need high titer viral stock like in vivo experiments.
Concentration protocols based on ultrafiltration were
also established for HIV-1 based vectors. Reiser et al.
(1996) have developed a facile ultrafiltration proce-
dure based on centriprep units (Millipore, Bedford,
MA) to concentrate HIV-1 pseudotypes. Good recov-
eries have been reported based on this procedure
(Reiser 2000).
Large-scale production of Lentiviral vector for both
in vivo and in vitro applications is very challenging
due to lack of simple and cost-benefit procedures that
could be capable of efficient processing of large
volumes of cell culture supernatant in a reasonable
amount of time.
The traditional ultracentrifugation approaches are
limited in terms of their capacity to handle large
volumes and costs. Overnight low speed centrifugation
has been used to process small to large volumes of up to
l000 ml of virus containing supernatant produced in
Nunc Cell Factories (Nalge Nunc, Naperville, IL)
(VandenDriessche et al. 2002). However this low-speed
approach is time consuming and has low efficiency.
There is an emerging need for quick, reproducible,
efficient, cost-benefit and less laborious procedures
that could rapidly reduce the volume of the superna-
tant need to be processed. Pham et al. (2001) have
developed a simple and gentle precipitation method
that could rapidly reduce the volume of both MoMLV
and lentiviral vectors involving the precipitation of
pH-adjusted viral supernatants with calcium phos-
phate, low-speed centrifugation and dialysis. The
volume can be decreased from 300 to 10 ml with
50–100 % recovery rate. Zhang et al. (2001) have
presented an alternative precipitation method based on
poly-L-lysine (PLL). In this method, viral vector
containing supernatants were mixed with PLL, incu-
bated at 4 C for 30 min, and centrifuged at
10,000g for 2 h; reports have shown that recovery
rate for processing of up to 3 liters of cell culture was
26-32 %.
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The aim of this study was to produce high titer
lentivirus based vectors that could be used for gene
delivery purposes.
Materials and methods
Cells and culture
Chinese hamster Ovary (CHO), Human Embryonic
Kidney (HEK) 293T, Human hepatocyte carcinoma
(HepG2), human breast adenocarcinoma (MCF-7),
Mouse embryonic Fibroblast (MEF) and Jurkat cell line
were obtained from the National Cell bank of Iran
(NCBI) and were grown in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10 % FCS (Gibco, Life
Technologies, Carlsbad, CA, USA) and 100 U/ml
penicillin (Life Technologies), 100 lg/ml streptomycin
(Life Technologies) and 2 mM glutamine (Life Tech-
nologies). The cells were plated in 75 cm2 flasks
(Orange Scientific, Braine-l’Alleud, Belgium) and cul-
tured in DMEM at 37 C in a humidified atmosphere of
95 % air/5 % CO2 with medium exchanges every
3 days. Following 2 weeks of incubation, the cells were
suspended in and then harvested from the medium.
Vector generation
Lentivirus-based vector expressing GFP was generated
by transient co-transfection of 293T cells with a three-
plasmid combination, HBS2X. Briefly, a 100 mm dish
of non-confluent 4 9 106 cells were transfected with. 3
lg of psPAX2 (Addgene, Cambridge, MA, USA,
Plasmid 12260), 1.5 lg of pMD2G (Addgene, Plasmid
12259), and 6 lg of lentiviral vector plasmid
(pWPXLd) mixed with 500 ll diluent (660 lL TE
0.1X, 350 ml ddH2O, 113 lL CaCl2 2.5 M, 5 mM
HEPES, 150 mM NaCl, pH = 7.05) and incubated at
room temperature (RT) for 15 min. Following the
incubation, 1,100 ml HBS2X was added to the mixture,
incubated at RT for 5 min and added to partially
confluent HEK 293T cells. 36, 48 and 72 h’s post-
transfection, Lentivirus containing supernatant was
harvested and used for next experiments.
Concentration of lentivirus-based vector
Two concentration methods were used to concentrate
vector containing supernatant. In ultracentrifuge-
based method, the supernatant was spinned at
47,000g for 2 h and the pellet was resuspended in
100–200 lL PBS 1X. In the precipitation-based
method, 8.5 % poly-ethyleneglycol (PEG) 8,000 and
0.4 M NaCl were added to lentiviral vector containing
supernatant and incubated at 4 C for 5 h along with
mixing every 20 min. Subsequently, the mixture was
pelleted at 7000 g for 15 min and the pellet was re-
suspended in 100–200 lL of PBS 1X.
Titration of lentivirus vector
Titration of eGFP expressing lentivirus vector was
carried out by transduction of HEK 293T cells.
Briefly, 106 HEK 293T cells were plated onto 24 well
plate in 1 ml medium per well. Subsequently, these
cells were transduced with four and sixfold dilutions
of the vector and 3 days post transduction, the eGFP
expressing cells were analyzed using fluorescent
activated cell sorting (FACS) method for each dilu-
tion. The titer was calculated based on following
formula:
Cell number 9 2 (doubling factor in 24 h) 9 %
eGFP? cells 9 1,000/lL virus.
Cell transduction
Transduction of HEK-293T, CHO, HepG2, MCF-7,
Jurkat cell lines and Mouse embryonic Fibroblast
(MEFs) were carried out with indicated cell numbers
and multiplicities of infections (MOIs) of the vector
for 2 h in the presence of 8 lg/ml of polybrene. Cells
were prepared so that theywere growing exponen-
tially and were no more than 70–80 % confluent
before transduction. At day 1, 1.5 x 104 cells added
in fresh medium to the wells of 96-well plate (Nunc,
Roskilde, Denmark) followed by incubation for
18-20 hours at 37 C in a humidified incubator in
an atmosphere of 5–7 % CO2. At day 2, medium
removed from wells and to each well 110 lL
medium and polybrene to a final concentration of 8
lg/ml were added. Ten lL of lentiviral vectors was
added to appropriate wells, gently mixed and incu-
bated for 18–20 hours at 37 C in a humidified
incubator in an atmosphere of 5–7 % CO2. Due to
toxicity concerns of lentiviral vectors, MEFs were
incubated for 2 to 4 hours before changing the
medium containing lentiviral vectors.
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In vitro lentivirus-based vector transduction
efficiency
Cells were seeded in 96-well plates (Nalge Nunc) at a
density of 2 9 103/well, and 0.5 ml DMEM with 1 %
penicillin–streptomycin and 15 % FBS was added to
each well. Viral particles at an MOI of 2.5, 5, 10, 20,
50, and 100 were added to the wells. Following
incubation at 37 C in 5 % CO2 for 24 h, the virus-
containing medium was removed and replaced with
0.5 ml fresh culture medium per well. The transduc-
tion efficiency was determined daily with an inverted
fluorescent microscope (DMI3000B; Leica, Wetzlar
Germany) and was quantified by measuring the GFP-
expressing cells as a percentage of the total number of
visible cells.
Results
Construction of GFP expressing lentiviral vector
using of HEK-293 T-cells
HEK 293T cell line was transfected with the plasmids
pWPXLd, pMD2G, psPAX2, to produce a GFP
expressing lentiviral vector. 36 hours post-transfec-
tion, fluorescent microscopy showed that GFP was
expressed in more than 70 % of these cells (Fig. 1).
Concentration and titration of GFP expressing
lentiviral vector
Using both ultracentrifuge-based and precipitation-
based methods, lentiviral containing supernatant was
concentrated and subsequently used for titration.
3 days post transduction of HEK 293T cells with 4
and sixfold dilutions of the vector, FACS analysis
showed that after only one-round of concentration by
ultracentrifugation at 50,000g, titers of (2.2 ± 1.0)
108 TU/ml on 293T cells were routinely achieved.
Time kinetics of gene expression in lentivirus
based vector using of HEK-293 T cells
To analyze the kinetics of lentiviral vector productions
in further detail and to investigate the possibility of
GFP expression over time, HEK 293T cells were
continuously passaged after infection and the percent-
age of GFP-expressing cells was determined by FACS
analysis on days 4, 6, 10, 14, 17, 24, and 90 post-
infection. In both cell lines, the percentage of GFP-
positive cells was stable throughout the culture period
and the percentage of GFP-positive cells correlated
with the promoter. These results indicate that trans-
gene expression levels are stable for at least 90 days
(Fig. 2).
Transduction of CHO, Jurkat, HepG2, MEFs
and MCF-7 cell lines
Our results showed that the cell lines HEK 293T,
CHO, Jurkat, HepG2, MCF-7 and MEFs were effi-
ciently transduced with the vector. 72 hours post
transduction, the transduction rate was analyzed using
direct fluorescence microscopy technique. Based on
the results, GFP was expressed in more than 95 % of
the transduced cells including MCF-7 (Fig. 3), Jurkat
Fig. 1 GFP expression in HEK-293 T cells 3 days posttrans-
fection of HEK-293 T-cells with the lines with the plasmids,
phase contrast microscopy (a), fluorescent microscopy (b), and
light microscopy; showed that due to transfection with the
plasmids,GFP expressing lentiviral vector was produced in
more than 70 % of the cells
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(Fig. 4), HepG2 (Fig. 6), and MEFs (Fig. 7). Base on
the FACS analysis, the transduction rate of CHO
(Fig. 5) and HEK 293T cells was 99.2 % and 96 %,
respectively.
Discussion
Lentivirus-based vectors constitute a valuable tool for
gene transfer technology. The vectors are traditionally
produced by transient cotransfection of human
embryonic kidney 293T cells using three to four
different plasmids (Addgene plasmid repository). A
successful gene delivery experiment using lentivirus-
based vector depends on a good co-transfection of
constituting plasmids on packaging cell line and an
efficient concentration method. In this work, for
generation of this vector, we used a 3-plasmid system
in the 293 T cell line. Based on our results 72 h post-
transfection, fluorescent microscopy showed that this
vector was produced in more than 70 % of these cells
(Fig. 1).
Fig. 2 Time kinetics of gene expression lentivirus vector in HEK-293 T cells. Figures a–d show efficient long term GFP expression in
HEK-293 T cell lines 3–90 days post transduction. a day 3, b day 10, c day 45, d day 90
Fig. 3 Transduction of MCF-7 cells with GFP expressing lentiviral vector. MCF-7 cells were transduced with the vector. 72 h post
transduction, light microscopy (a) and fluorescent microscopy (b) results showed that 95 % of the cells were transduced with the vector
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Studies have shown that the efficiency of lentivirus-
based vector can be significantly improved by con-
centration and removal of impurities (Zimmermann
et al. 2011). Typical virus titers range from 106 to 107
transducing units per milliliter (TU/ml). Increased
titers can be achieved by concentration of the culture
supernatants by ultracentrifugation (Naldini et al.
1996). Pseudotyped lentiviral particles containing the
VSV-G glycoprotein used in this work, have been
shown to be quite stable and withstand concentration
Fig. 4 Transduction of Jurkat cells with GFP expressing
lentiviral vector. Jurkat cells were transduced with the vector.
72 h post transduction, light microscopy (a) and fluorescent
microscopy (b) results showed that the 95 % of the cells were
transduced with the vector
Fig. 5 Transduction of CHO cells with GFP expressing
lentiviral vector. CHO cells were transduced with the vector.
72 h post transduction, light microscopy (a), fluorescent
microscopy (b), and DAPI staining (c) results showed that
99.2 % of the cells were transduced with the vector
Fig. 6 Transduction of HepG2 cells with GFP expressing lentiviral vector. HepG2 cell were transduced with the vector. 72 h post
transduction, light microscopy (a) and fluorescent microscopy (b) results showed that 95 % of the cells were transduced with the vector
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by ultracentrifugation without significant loss in titer
(Fig. 2). This might open up a way to generate highly
concentrated vector stocks for in vivo applications in
our laboratory.
To analyze the kinetics of the transgene (GFP)
expression, HEK 293T cells were transduced with the
viral vector and expression of GFP in the expressing
cells was followed up to more than 3 months. As Fig. 2
shows, frequent passage of the cells had no effect on
GFP expression indicating that these cells became
transgenic.
Our results showed that the vector transduced the
dividing cells CHO, Jurkat, HepG2, and MCF-7 and
MEFs efficiently with the rate of more than 95 % after
72 h. These cells are dividing cells and are widely used
in different research fields. It has been demonstrated that
GFP expressing lentivirus efficiently deliver transgene
into HepG2 cells and that two lentiviral constructs are
highly efficient for silencing apoB expression in these
cells (Liao and Ning 2006). Accordingly, Jurkat cell is
used to study the expression of various chemokine
receptors susceptible to viral entry, MCF-7 is used in
cancer research, and CHO is being used especially when
long-term, stable gene expression and high yields of
proteins are required. Therefore, the vector generated in
this work would be a promising tool in the expression of
therapeutic genes in both dividing and non-dividing cell
lines in vitro and may be in vivo as well.
Conclusion
Our results showed that GFP expressing lentivirus-
based vector, generated in this study, can transduce
efficiently dividing cells CHO, Jurkat, HepG2, MCF-7
and MEFs. Conclusively, the method used in this work
is a simplified, easy to set up, reproducible, efficient,
cost-benefit and less laborious method for generation
of a lentivirus-based vector that could be used in a
wide range of gene delivery experiments.
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